Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19
Samantha A. Burgess(Pacific Northwest National Laboratory), Mikhail Reibarkh(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yu‐hong Lam(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ryan D. Cohen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yunyi Wang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dirk Stueber(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xiao Wang(Nanjing University), Luca Iuzzolino(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 0
Related Papers
Report on the sixth blind test of organic crystal structure prediction methods
|Acta Crystallographica Section B Structural Science Crystal Engineering and Materials|2016|606
The merger of decatungstate and copper catalysis to enable aliphatic C(sp3)–H trifluoromethylation
|Nature Chemistry|2020|350
Photomediated ring contraction of saturated heterocycles
|Science|2021|245
Bright Stretchable Electroluminescent Devices based on Silver Nanowire Electrodes and High-k Thermoplastic Elastomers
|ACS Applied Materials & Interfaces|2018|113
Hydrogenation of CO<sub>2</sub> in Water Using a Bis(diphosphine) Ni–H Complex
|ACS Catalysis|2017|88